| Literature DB >> 21887281 |
Cinzia Cantacessi1, Neil D Young, Peter Nejsum, Aaron R Jex, Bronwyn E Campbell, Ross S Hall, Stig M Thamsborg, Jean-Pierre Scheerlinck, Robin B Gasser.
Abstract
BACKGROUND: Iatrogenic infection of humans with Trichuris suis (a parasitic nematode of swine) is being evaluated or promoted as a biological, curative treatment of immune diseases, such as inflammatory bowel disease (IBD) and ulcerative colitis, in humans. Although it is understood that short-term T. suis infection in people with such diseases usually induces a modified Th2-immune response, nothing is known about the molecules in the parasite that induce this response. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2011 PMID: 21887281 PMCID: PMC3160910 DOI: 10.1371/journal.pone.0023590
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of the nucleotide sequence data for adult Trichuris suis prior and following assembly, as well as detailed bioinformatic annotation and analyses.
|
| 64,496,406 |
| Contigs (average length ± SD; min–max length) | 19,823 (1480±1577.22; 101–20,908) |
| GC content (%) | 44.22 |
| Raw reads mapped to contigs (%) | 39,659,580 (61.5) |
| Containing an Open Reading frame (%) | 17,646 (90) |
| With homologues in | 8,353 (47) |
|
| 10,324 (58.5) |
|
| 9,749 (49.1) |
|
| 8,161 (46.2) |
| other parasitic nematodes (%) | 15,533 (78) |
| other organisms (%) | 9,214 (46) |
| Returning InterProScan results (%) | 12,113 (68.6) |
|
| 3,534 |
| Gene Ontology (%) | 10,248 (58) |
|
| 316 |
|
| 104 |
|
| 457 |
| Returning a KOBAS result (%) | 4,588 (26) |
| Number of predicted biological pathways (KEGG) | 262 |
| Predicted proteins with signal peptides (%) | 1,992 (11.2) |
| with transmembrane domains (%) | 3,004 (17) |
| Homologous to proteins in the SPD database (%) | 5,548 (31.4) |
| Predicted excretory/secretory proteins | 1,288 (7.3) |
*Inferred based on the presence of a signal peptide and homology to known proteins in the SPD database.
Figure 1Similarity searches.
Venn diagram illustrating the overlap in amino acid sequence homology between and among Trichuris suis and selected species of the class Enoplea (i.e., Trichinella spiralis) and Chromadorea (i.e., Caenorhabditis elegans, Pristionchus pacificus and Meloidogyne hapla).
Figure 2Gene Ontology.
Bar graph illustrating similarities and differences between Gene Ontology (GO) terms (according to the categories ‘cellular component’ and ‘molecular function’ and ‘biological process’) assigned to peptides from Trichuris suis and Trichinella spiralis inferred from transcriptomic and genomic data, respectively, plotted using a web-based tool, WEGO [41].
Composition of putative excreted/secreted proteins inferred from the transcriptome of adult Trichuris suis and corresponding (conserved) signature protein motifs.
| Predicted proteins | Number (%) | Pfam domain(s) (code)/number of putative peptides |
|
|
| |
| Serine proteases | 42 | Serine carboxypeptidase (PF05577.5); |
| 29 | Rhomboid serine protease (PF12595.1); | |
| 27 | Serine proteinase (PF01972.9) | |
| Metalloproteases | 38 | Zinc metalloprotease (PF01421.12); |
| 22 | Metallopeptidase family (PF00557.17); | |
| 18 | Aminopeptidase I zinc metalloprotease (PF02127.8) | |
| Cysteine proteinase | 32 | Cysteine protease (PF00548.13) |
| 12 | Calpain family cystein protease (PF00648.14) | |
| Aspartyl proteases | 6 | Eukaryotic aspartyl protease (PF00026.16); |
| 4 | Aspartyl protease (PF09668.3); | |
| 2 | Retroviral aspartyl protease (PF00077.13) | |
| Other peptidases | 41 | Peptidase family (PF03416.12; PF01431.14; PF01435.11); |
| 8 | Trypsin (PF00089.19) | |
|
|
| |
| 161 | Uncharacterised protein families (PF03665.6; PF03650.6)/161; | |
| 39 | Uncharacterised, conserved proteins (PF09758.2; PF10103.2; PF10171.2; PF10217.2; PF10225.2; PF10229.2; PF10164.2; PF10226.2) | |
|
|
| |
| Hexokinases | 27 | Hexokinase (PF00349.14) |
| Serine/threonine kinases | 17 | Serine/threonine protein kinase (PF05445.4) |
| Acylglycerol-kinases | 9 | Dyacylglycerol kinase (PF00609.12; PF00781.17) |
| Other kinases | 24 | Adenylate kinase (PF00406.15); |
| 19 | Protein kinase domain (PF00069.18); | |
| 19 | Phosphofructokinase (PF00365.13); | |
| 16 | Pyruvate kinase (PF02887.9); | |
| 5 | Calcium-calmodulin dependent protein kinase (PF08332.3); | |
| 5 | Fructosamine kinase (PF03881.7); | |
| 2 | Deoxynucleoside kinase (PF01712.12) | |
|
|
| |
| Lipid receptors | 7 | Low-density lipoprotein receptor (PF00057.11; PF00058.10) |
| Other receptors | 41 | A-macroglobulin receptor (PF07677.7); |
| 30 | B cell receptor associated (PF05529.5); | |
| 22 | Transient receptor ion channel (PF08344.4); | |
| 13 | Ephrin receptor ligand binding (PF01404.12); | |
| 11 | Inositol triphosphate/ryanodine receptor (PF08709.4); | |
| 8 | G protein-coupled receptor (PF12205.1); | |
| 3 | Natural killer receptor (PF11465.1) | |
|
|
| |
| 133 | Conserved hypothetical protein (PF03602.8); | |
| 8 | Conserved hypothetical ATP-binding protein (PF03029.10); | |
| 2 | Hypothetical methyltransferase (PF05148.8) | |
|
|
| |
| 60 | Transcription elongation factor (PF05129.6); | |
| 51 | Transcription factor (PF01096.11; PF00382.12; PF00352.14) | |
| 21 | CP2 transcription factor (PF04516.8) | |
|
|
| |
| Kunitz-type protease inhibitors | 45 | Kunitz-type protease inhibitor domain (PF00014.16) |
| Serine-protease inhibitors | 11 | Serine protease inhibitor domain (PF00050.14); |
| 2 | Serpin (PF00079.13) | |
| Other protease inhibitors | 28 | Cathepsin inhibitor domain (PF08246.5) |
|
|
| Eukaryotic porin (PF01459.15) |
|
|
| |
| 102 | Helicase conserved domain (PF00271.24); | |
| 39 | ATPase family (PF00004.22); | |
| 5 | Macrophage migration inhibitory factor (PF01187.11) |
*Including n = 5 serine proteases with identity (92%) to known ‘secretory leukocyte protease inhibitors’ from Mus musculus.
Figure 3Immuno-modulatory mechanisms.
Cascade of immuno-molecular events hypothesized to lead to the modulation of immune response in Trichuris suis-infected humans. Molecules linked to the T-cell receptor and chemokine signalling pathways could be involved in the stimulation of the Th2-type immune response, which, in turn, stimulates the expansion of populations of pro-inflammatory cells and cytokines. T. suis homologues of secreted leukocyte protease inhibitors (SLPIs) could inhibit hyper-responsiveness of the immune system by down-regulating the activity of Th2-type cells.